Skip to content
★ Sign in to follow
MG
Total declarations
145
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (77 ops.)
€23.0M

Latest filing published 02 Jun 2020 for ABIOMED INC.

Filing timeline

BuySale
Michael G. Howley

Insider track record

Disclosed buys
0
Disclosed sells
77
Signal history

Michael G. Howley: trading record in brief

Michael G. Howley is a declared insider of Abiomed Inc, with filings sourced from SEC (Form 4). Over a trading history stretching from 12 August 2009 to 29 May 2020, the count stands at 145 filings.

Sales make up the whole of the open-market record (77 sales, €23.0M). Besides market trades, the filings include 40 share grants and 24 option exercises.

Most recently, on 2 June 2020, the filings show a share grant in Abiomed Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Michael G. Howley

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations144 total
  • ◆
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    0SEC
    600 shares0Common Stock, $.01 par valueSEC:0001179110-20-006839:0
  • ◆
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    273,825 USD17SEC
    1,486 shares@ US$184.2757.5% of flowCommon Stock, $.01 par valueSEC:0001179110-20-006303:0
  • ◆
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    49,200 USD12SEC
    267 shares@ US$184.2710.3% of flowCommon Stock, $.01 par valueSEC:0001179110-20-006303:1
  • ◆
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    38,833 USD12SEC
    210 shares@ US$184.928.1% of flowCommon Stock, $.01 par valueSEC:0001179110-20-006303:2
  • ◆
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    114,650 USD13SEC
    620 shares@ US$184.9224.1% of flowCommon Stock, $.01 par valueSEC:0001179110-20-006303:3
  • ◆
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    0SEC
    146 shares0Common Stock, $.01 par valueSEC:0001179110-20-004524:0
  • ◆
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    0SEC
    90 shares0Common Stock, $.01 par valueSEC:0001179110-19-010752:0
  • ●
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    0SEC
    18,010 shares0Common Stock, $.01 par valueSEC:0001179110-19-007011:0
  • ●
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    0SEC
    18,010 shares0Common Stock, $.01 par valueSEC:0001179110-19-007011:1
  • ◆
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    389,495 USD11SEC
    1,483 shares@ US$262.642.8% of flowCommon Stock, $.01 par valueSEC:0001179110-19-006788:0
  • ◆
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    0SEC
    4,179 shares0Common Stock, $.01 par valueSEC:0001179110-19-006273:2
  • ◆
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    380,158 USD11SEC
    1,481 shares@ US$256.692.7% of flowCommon Stock, $.01 par valueSEC:0001179110-19-006273:0
  • ◆
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    68,536 USD11SEC
    267 shares@ US$256.690.5% of flowCommon Stock, $.01 par valueSEC:0001179110-19-006273:1
  • ◆
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    54,013 USD11SEC
    208 shares@ US$259.680.4% of flowCommon Stock, $.01 par valueSEC:0001179110-19-006273:3
  • ◆
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    161,002 USD11SEC
    620 shares@ US$259.681.2% of flowCommon Stock, $.01 par valueSEC:0001179110-19-006273:4
  • ◇
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    231,500 USD11SEC
    10,000 shares@ US$23.151.4% of flowCommon Stock, $.01 par valueSEC:0001179110-18-011667:0
  • ▼
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    2M USD24SEC
    5,000 shares@ US$425.0012.8% of flowCommon Stock, $.01 par valueSEC:0001179110-18-011667:1
  • ▼
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    2M USD24SEC
    5,000 shares@ US$440.0013.3% of flowCommon Stock, $.01 par valueSEC:0001179110-18-011667:2
  • ◆
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    586,952 USD11SEC
    1,484 shares@ US$395.522.2% of flowCommon Stock, $.01 par valueSEC:0001179110-18-007553:0
  • ◆
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    0SEC
    1,400 shares0Common Stock, $.01 par valueSEC:0001179110-18-007134:0
  • ●
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    0SEC
    2,500 shares0Common Stock, $.01 par valueSEC:0001179110-18-007134:1
  • ●
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    0SEC
    2,500 shares0Common Stock, $.01 par valueSEC:0001179110-18-007134:2
  • ◆
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    0SEC
    10,000 shares0Common Stock, $.01 par valueSEC:0001179110-18-006920:1
  • ◆
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    719,272 USD11SEC
    1,930 shares@ US$372.682.7% of flowCommon Stock, $.01 par valueSEC:0001179110-18-006920:0
  • ◆
    VP, Global Sales & MarketingExecutivesAbiomed Inc
    657,798 USD11SEC
    1,751 shares@ US$375.672.5% of flowCommon Stock, $.01 par valueSEC:0001179110-18-006920:2

25 of 144 declarations